Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma-Reference-Cited by-同舟云学术

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

Published:2000-05 Issue:10 Volume:7 Page:859-866
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Rampling R,Cruickshank G,Papanastassiou V,Nicoll J,Hadley D,Brennan D,Petty R,MacLean A,Harland J,McKie E,Mabbs R,Brown M

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/3301184.pdf

Reference34 articles.

1. Rampling R . Modern aspects of radiation therapy for glial tumours of the brain Forum 1998 8: 289–301

2. Rampling R . Chemotherapy. Determining the appropriate treatment. In: Hopkins A, Davies EH (eds) Improving Care for Patients with Malignant Glioma Royal College of Physicians: London 1997 pp 63–74

3. Rajan B . et al. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy Eur J Cancer 1994 30A: 1809–1815

4. Gutin P, Leibel S . Stereotaxic interstitial irradiation of malignant brain tumours Neurol Clin 1985 3: 883–893

5. Mbidde EK et al. High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma Br J Cancer 1988 58: 779–782

Cited by 519 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of non-replicative and oncolytic replication-selective HSV vectors;Trends in Molecular Medicine;2024-08

2. Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review;Annals of Medicine & Surgery;2024-07-17

3. Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms;International Journal of Molecular Sciences;2024-06-19

4. Targeting Cancers with oHSV-Based Oncolytic Viral Immunotherapy;Current Issues in Molecular Biology;2024-06-03

5. Immunotherapeutic Strategies for the Treatment of Glioblastoma: Current Challenges and Future Perspectives;Cancers;2024-03-25